Design Therapeutics, Inc. (DSGN)
Pharmaceutical Preparations
Latest Price
$12.22
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.26
P/B Ratio
3.75
Institutional Ownership
70.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SR One Capital Management, LP | 6.53M | $94.0M | 10.43% | -- | 2026-06-30 |
| Logos Global Management LP | 3.00M | $43.0M | 4.79% | +1.05M | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 2.68M | $38.0M | 4.28% | +92.5K | 2026-06-30 |
| Driehaus Capital Management LLC | 2.66M | $38.0M | 4.25% | +916.1K | 2026-06-30 |
| BlackRock, Inc. | 2.66M | $38.0M | 4.25% | +526.3K | 2026-06-30 |
| Caption Management, LLC | 2.62M | $37.0M | 4.18% | +2.53M | 2026-06-30 |
| Point72 Asset Management, L.P. | 2.37M | $34.0M | 3.78% | -356.3K | 2026-06-30 |
| Trails Edge Capital Partners, LP | 2.00M | $28.0M | 3.20% | +1.15M | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 1.81M | $26.0M | 2.89% | +1.29M | 2026-06-30 |
| Vivo Capital, LLC | 1.61M | $23.0M | 2.58% | -- | 2026-06-30 |